Smithfield Fiduciary LLC Watch

from SC 13G/A 1 page Exhibit I Joint Filing Agreement This Will Confirm the Agreement by and Among the Undersigned That the Schedule 13g/a Filed With the Securities and Exchange Commission on or About the Date Hereof With Respect to the Beneficial Ownership by the Undersigned of the Class "A" Ordinary Shares of Trinity Biotech Plc Is Being Filed, and All Amendments Thereto Will Be Filed, on Behalf of Each of the Persons and Entities Named Below in Accordance With Rule 13d-1(k) Under the Securities Exchange Act of 1934, as Amended. This Agreement May Be Executed in Two or More Counterparts, Each of Which Shall Be Deemed an Original, but All of Which Together Shall Constitute One and the Same Instrument. Dated: February 11, 2005 Smithfield Fiduciary LLC By: /S/ Howard Feitelberg Howard Feitelberg, Director Highbridge International LLC By: /S/ Howard Feitelberg Howard Feitelberg, Director Highbridge Capital Corporation By: /S/ Howard Feitelberg Howard Feitelberg, Controller Highbridge Capital Management, LLC By: /S/ Ronald S. Resnick Ronald S. Resnick, Managing Partner /S/ Glenn Dubin - Glenn Dubin /S/ Henry Swieca - Henry Swieca

from SC 13G/A 1 page Exhibit I Joint Filing Agreement This Will Confirm the Agreement by and Among the Undersigned That the Schedule 13g/a Filed With the Securities and Exchange Commission on or About the Date Hereof With Respect to the Beneficial Ownership by the Undersigned of the Common Stock, Par Value $0.01 Par Share of Entremed, Inc. Is Being Filed, and All Amendments Thereto Will Be Filed, on Behalf of Each of the Persons and Entities Named Below in Accordance With Rule 13d-1(k) Under the Securities Exchange Act of 1934, as Amended. This Agreement May Be Executed in Two or More Counterparts, Each of Which Shall Be Deemed an Original, but All of Which Together Shall Constitute One and the Same Instrument. Dated: February 11, 2005 Smithfield Fiduciary LLC By: /S/ Howard Feitelberg Howard Feitelberg, Director Highbridge International LLC By: /S/ Howard Feitelberg Howard Feitelberg, Director Highbridge Capital Corporation By: /S/ Howard Feitelberg Howard Feitelberg, Controller Highbridge Capital Management, LLC By: /S/ Ronald S. Resnick Ronald S. Resnick, Managing Partner /S/ Glenn Dubin - Glenn Dubin /S/ Henry Swieca - Henry Swieca

from SC 13G/A 1 page Exhibit I Joint Filing Agreement This Will Confirm the Agreement by and Among the Undersigned That the Schedule 13g/a Filed With the Securities and Exchange Commission on or About the Date Hereof With Respect to the Beneficial Ownership by the Undersigned of the Common Stock of Guilford Pharmaceuticals Inc. Is Being Filed, and All Amendments Thereto Will Be Filed, on Behalf of Each of the Persons and Entities Named Below in Accordance With Rule 13d-1(k) Under the Securities Exchange Act of 1934, as Amended. This Agreement May Be Executed in Two or More Counterparts, Each of Which Shall Be Deemed an Original, but All of Which Together Shall Constitute One and the Same Instrument. Dated: February 11, 2005 Smithfield Fiduciary LLC By: /S/ Howard Feitelberg Howard Feitelberg, Director Highbridge International LLC By: /S/ Howard Feitelberg Howard Feitelberg, Director Highbridge Capital Corporation By: /S/ Howard Feitelberg Howard Feitelberg, Controller Highbridge Capital Management, LLC By: /S/ Ronald S. Resnick Ronald S. Resnick, Managing Partner /S/ Glenn Dubin - Glenn Dubin /S/ Henry Swieca - Henry Swieca

from SC 13G/A 1 page Exhibit 1 Joint Filing Agreement This Will Confirm the Agreement by and Among the Undersigned That the Schedule 13g/a Filed With the Securities and Exchange Commission on or About the Date Hereof With Respect to the Beneficial Ownership by the Undersigned of the Common Stock of Avi Biopharma, Inc. Is Being Filed, and All Amendments Thereto Will Be Filed, on Behalf of Each of the Persons and Entities Named Below in Accordance With Rule 13d-1(k) Under the Securities Exchange Act of 1934, as Amended. This Agreement May Be Executed in Two or More Counterparts, Each of Which Shall Be Deemed an Original, but All of Which Together Shall Constitute One and the Same Instrument. Dated: February 11, 2005 Smithfield Fiduciary LLC By: /S/ Howard Feitelberg Howard Feitelberg, Director Highbridge International LLC By: /S/ Howard Feitelberg Howard Feitelberg, Director Highbridge Capital Corporation By: /S/ Howard Feitelberg Howard Feitelberg, Controller Highbridge Capital Management, LLC By: /S/ Ronald S. Resnick Ronald S. Resnick, Managing Partner /S/ Glenn Dubin - Glenn Dubin /S/ Henry Swieca - Henry Swieca

from SC 13G/A 1 page Exhibit Index Exhibit Description 1 Joint Filing Agreement Exhibit 1 Joint Filing Agreement in Accordance With Rule 13d-1(k) (1) (III) Under the Securities Exchange Act of 1934, as Amended, the Persons Named Below Agree to the Joint Filing on Behalf of Each of Them of a Statement on Schedule 13g/a Dated March 8, 2004 (Including Amendments Thereto) With Respect to the Class "A" Ordinary Shares of Trinity Biotech PLC. This Joint Filing Agreement Shall Be Filed as an Exhibit to Such Statement. Dated: March 8, 2004 Smithfield Fiduciary LLC By: /S/ Howard Feitelberg Howard Feitelberg, Director Highbridge International LLC By: /S/ Howard Feitelberg Howard Feitelberg, Director Highbridge Capital Corporation By: /S/ Howard Feitelberg Howard Feitelberg, Controller Highbridge Capital Management, LLC By: /S/ Ronald S. Resnick Ronald S. Resnick, Managing Director

from SC 13G 1 page Exhibit 1 Joint Filing Agreement in Accordance With Rule 13d-1(k) (1) (III) Under the Securities Exchange Act of 1934, as Amended, the Persons Named Below Agree to the Joint Filing on Behalf of Each of Them of a Statement on Schedule 13g Filed on December 19, 2003 (Including Amendments Thereto) With Respect to the Common Stock of Guilford Pharmaceuticals Inc. This Joint Filing Agreement Shall Be Filed as an Exhibit to Such Statement. Dated: December 19, 2003 Smithfield Fiduciary LLC By: /S/ Howard Feitelberg Howard Feitelberg, Director Highbridge International LLC By: /S/ Howard Feitelberg Howard Feitelberg, Director Highbridge Capital Corporation By: /S/ Howard Feitelberg Howard Feitelberg, Controller Highbridge Capital Management, LLC By: /S/ Ronald S. Resnick Ronald S. Resnick, Managing Director

from SC 13G 1 page Exhibit 1 Joint Filing Agreement in Accordance With Rule 13d-1(k) (1) (III) Under the Securities Exchange Act of 1934, as Amended, the Persons Named Below Agree to the Joint Filing on Behalf of Each of Them of a Statement on Schedule 13g Filed on December 15, 2003 (Including Amendments Thereto) With Respect to the Common Stock of Avi Biopharma, Inc. This Joint Filing Agreement Shall Be Filed as an Exhibit to Such Statement. Dated: December 15, 2003 Smithfield Fiduciary LLC By: /S/ Howard Feitelberg Howard Feitelberg, Director Highbridge International LLC By: /S/ Howard Feitelberg Howard Feitelberg, Director Highbridge Capital Corporation By: /S/ Howard Feitelberg Howard Feitelberg, Controller Highbridge Capital Management, LLC By: /S/ Ronald S. Resnick Ronald S. Resnick, Managing Director

from SC 13G 1 page Exhibit 1 Joint Filing Agreement in Accordance With Rule 13d-1(k) (1) (III) Under the Securities Exchange Act of 1934, as Amended, the Persons Named Below Agree to the Joint Filing on Behalf of Each of Them of a Statement on Schedule 13g Filed on November 10, 2003 (Including Amendments Thereto) With Respect to the Common Stock of Entremed, Inc. This Joint Filing Agreement Shall Be Filed as an Exhibit to Such Statement. Dated: November 10, 2003 Smithfield Fiduciary LLC By: /S/ Howard Feitelberg Howard Feitelberg, Director Highbridge International LLC By: /S/ Howard Feitelberg Howard Feitelberg, Director Highbridge Capital Corporation By: /S/ Howard Feitelberg Howard Feitelberg, Controller Highbridge Capital Management, LLC By: /S/ Ronald S. Resnick Ronald S. Resnick, Managing Director

from SC 13G 1 page Exhibit Index Exhibit Description 1 Joint Filing Agreement Exhibit 1 Joint Filing Agreement in Accordance With Rule 13d-1(k) (1) (III) Under the Securities Exchange Act of 1934, as Amended, the Persons Named Below Agree to the Joint Filing on Behalf of Each of Them of a Statement on Schedule 13g Dated September 15, 2003 (Including Amendments Thereto) With Respect to the Class "A" Ordinary Shares of Trinity Biotech PLC. This Joint Filing Agreement Shall Be Filed as an Exhibit to Such Statement. Dated: September 15, 2003 Smithfield Fiduciary LLC By: /S/ Howard Feitelberg Howard Feitelberg, Director Highbridge International LLC By: /S/ Howard Feitelberg Howard Feitelberg, Director Highbridge Capital Corporation By: /S/ Howard Feitelberg Howard Feitelberg, Controller Highbridge Capital Management, LLC By: /S/ Ronald S. Resnick Ronald S. Resnick, Managing Director

from SC 13G/A 1 page Exhibit 1 Joint Filing Agreement in Accordance With Rule 13d-1(k) (1) (III) Under the Securities Exchange Act of 1934, as Amended, the Persons Named Below Agree to the Joint Filing on Behalf of Each of Them of a Statement on Schedule 13g/a Filed on June 10, 2003 (Including Amendments Thereto) With Respect to the Common Stock of Genome Therapeutics Corp. This Joint Filing Agreement Shall Be Filed as an Exhibit to Such Statement. Dated: June 10, 2003 Smithfield Fiduciary LLC By: /S/ Howard Feitelberg Howard Feitelberg, Director Highbridge International LLC By: /S/ Howard Feitelberg Howard Feitelberg, Director Highbridge Capital Corporation By: /S/ Howard Feitelberg Howard Feitelberg, Controller Highbridge Capital Management, LLC By: /S/ Ronald S. Resnick Ronald S. Resnick, Managing Director

from SC 13G/A 1 page Exhibit 1 Joint Filing Agreement in Accordance With Rule 13d-1(k) (1) (III) Under the Securities Exchange Act of 1934, as Amended, the Persons Named Below Agree to the Joint Filing on Behalf of Each of Them of a Statement on Schedule 13g/a Dated (Including Amendments Thereto) With Respect to the Common Stock of Mutual Risk Management Ltd. This Joint Filing Agreement Shall Be Filed as an Exhibit to Such Statement. Dated: February 14, 2003 Smithfield Fiduciary LLC By: /S/ Howard Feitelberg Howard Feitelberg, Director Highbridge International LLC By: /S/ Howard Feitelberg Howard Feitelberg, Director Highbridge Capital Corporation By: /S/ Howard Feitelberg Howard Feitelberg, Controller Highbridge Capital Management, LLC By: /S/ Ronald S. Resnick Ronald S. Resnick, Managing Director

from SC 13G/A 1 page Exhibit 1 Joint Filing Agreement in Accordance With Rule 13d-1(k) (1) (III) Under the Securities Exchange Act of 1934, as Amended, the Persons Named Below Agree to the Joint Filing on Behalf of Each of Them of a Statement on Schedule 13g/a Dated (Including Amendments Thereto) With Respect to the Common Stock of Midway Games Inc. This Joint Filing Agreement Shall Be Filed as an Exhibit to Such Statement. Dated: February 14, 2003 Smithfield Fiduciary LLC By: /S/ Howard Feitelberg Howard Feitelberg, Director Highbridge International LLC By: /S/ Howard Feitelberg Howard Feitelberg, Director Highbridge Capital Corporation By: /S/ Howard Feitelberg Howard Feitelberg, Controller Highbridge Capital Management, LLC By: /S/ Ronald S. Resnick Ronald S. Resnick, Managing Director

from SC 13G 1 page Exhibit 1 Joint Filing Agreement in Accordance With Rule 13d-1(k) (1) (III) Under the Securities Exchange Act of 1934, as Amended, the Persons Named Below Agree to the Joint Filing on Behalf of Each of Them of a Statement on Schedule 13g Dated (Including Amendments Thereto) With Respect to the Common Stock of Mutual Risk Management Ltd. This Joint Filing Agreement Shall Be Filed as an Exhibit to Such Statement. Dated: December 10, 2001 Smithfield Fiduciary LLC By: /S/ Howard Feitelberg Howard Feitelberg, Director Highbridge International LLC By: /S/ Howard Feitelberg Howard Feitelberg, Director Highbridge Capital Corporation By: /S/ Howard Feitelberg Howard Feitelberg, Controller Highbridge Capital Management, LLC By: /S/ Ronald S. Resnick Ronald S. Resnick, Managing Director